High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients

被引:22
|
作者
Egawa, C [1 ]
Miyoshi, Y [1 ]
Taguchi, T [1 ]
Tamaki, Y [1 ]
Noguchi, S [1 ]
机构
[1] Osaka Univ, Sch Med, Dept Surg Oncol, Suita, Osaka 5650871, Japan
关键词
breast cancer; BRCA2; prognosis; ER; histologic grade;
D O I
10.1002/ijc.10231
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic significance of BRCA2 mRNA levels in tumor tissues was studied in sporadic breast cancer patients. BRCA2 mRNA levels were determined by real-time PCR. Histologic grade III tumors showed significantly (p = 0.001) higher BRCA2 mRNA levels (0.828 +/- 0.102 BRCA2/beta-glucuronidase mRNA ratio, mean +/- SE) than histologic grade I and II tumors (0.438 +/- 0.055) and estrogen receptor (ER)-negative tumors (0.773 +/- 0.102) showed a nonsignificant (p = 0.072) trend toward an increase in BRCA2 mRNA levels compared to ER-positive tumors (0.541 +/- 0.079). Other clinicopathologic parameters, such as menopausal status, lymph node status and tumor size, were not significantly associated with BRCA2 mRNA levels. Patients with high BRCA2 mRNA levels showed a significantly (p = 0.006) lower 5-year disease free survival rate (63%) than those with low levels (94%). Lymph node metastases, ER negativity and high histologic grade were also significantly (p < 0.05) associated with poor prognosis. Multivariate analysis revealed that BRCA2 mRNA levels were a significant prognostic factor, being independent of the other conventional prognostic factors. Our results suggest that BRCA2 mRNA levels might serve as a clinically useful prognostic factor in breast cancer patients. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:879 / 882
页数:4
相关论文
共 50 条
  • [41] Hereditary breast cancer - Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
    Marcus, JN
    Watson, P
    Page, DL
    Narod, SA
    Lenoir, GM
    Tonin, P
    LinderStephenson, L
    Salerno, G
    Conway, TA
    Lynch, HT
    CANCER, 1996, 77 (04) : 697 - 709
  • [43] High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level
    Chunsen Xu
    Mutsuko Yamamoto-Ibusuki
    Yutaka Yamamoto
    Satoko Yamamoto
    Saori Fujiwara
    Keiichi Murakami
    Yasuhiro Okumura
    Lisa Yamaguchi
    Yoshitaka Fujiki
    Hirotaka Iwase
    Breast Cancer, 2014, 21 : 482 - 490
  • [44] High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level
    Xu, Chunsen
    Yamamoto-Ibusuki, Mutsuko
    Yamamoto, Yutaka
    Yamamoto, Satoko
    Fujiwara, Saori
    Murakami, Keiichi
    Okumura, Yasuhiro
    Yamaguchi, Lisa
    Fujiki, Yoshitaka
    Iwase, Hirotaka
    BREAST CANCER, 2014, 21 (04) : 482 - 490
  • [45] High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients
    Fackenthal, James D.
    Zhang, Jing
    Zhang, Bifeng
    Zheng, Yonglan
    Hagos, Fitsum
    Burrill, Devin R.
    Niu, Qun
    Huo, Dezheng
    Sveen, Walmy E.
    Ogundiran, Temidayo
    Adebamowo, Clemet
    Odetunde, Abayomi
    Falusi, Adeyinka G.
    Olopade, Olufunmilayo I.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (05) : 1114 - 1123
  • [46] Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers
    Yan, Max
    Xu, Huiling
    Waddell, Nic
    Shield-Artin, Kristy
    Haviv, Izhak
    McKay, Michael J.
    Fox, Stephen B.
    BREAST CANCER RESEARCH, 2012, 14 (02):
  • [47] High APLN Expression Predicts Poor Prognosis for Glioma Patients
    Lv, Shuangyu
    An, Yang
    Dong, Huan
    Xie, Longxiang
    Zheng, Hong
    Cheng, Xiaoxia
    Zhang, Lei
    Teng, Tieshan
    Wang, Qiang
    Yan, Zhongyi
    Guo, Xiangqian
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [48] High expression of △Np73 predicts poor prognosis in NSCLC cancer patients
    何勇
    范士志
    蒋耀光
    陈建明
    胡义杰
    Journal of Medical Colleges of PLA, 2007, (02) : 101 - 105
  • [49] Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers
    Max Yan
    Huiling Xu
    Nic Waddell
    Kristy Shield-Artin
    Izhak Haviv
    Michael J McKay
    Stephen B Fox
    Breast Cancer Research, 14
  • [50] High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer
    Caiting Yang
    Peike Peng
    Lili Li
    Miaomiao Shao
    Junjie Zhao
    Lan Wang
    Fangfang Duan
    Shushu Song
    Hao Wu
    Jie Zhang
    Ran Zhao
    Dongwei Jia
    Mingming Zhang
    Weicheng Wu
    Can Li
    Yefei Rong
    Lei Zhang
    Yuanyuan Ruan
    Jianxin Gu
    Scientific Reports, 6